Francis X. Farrell - Concepedia

Author

Francis X. Farrell

Johnson & Johnson (United States)

Also Known As

F Farrell, F R Takeda, F X Farrell, F. X. Farrell, Francis Farrell, Francis X Farrell, Francis X. Farrell

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Johnson & Johnson (United States)Burroughs Wellcome Fund Scripps Research Institute National Institutes of Health University of California, San Francisco

About

Francis X. Farrell is an author at Johnson & Johnson (United States) specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.3K
2	Natural Sciences	6	6	414
3	Biochemistry	5	5	534
4	Health Sciences	1	1	46
5	Social Sciences	1	1	61

Francis X. Farrell

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative Tellen D. Bennett, Richard A. Moffitt, Janos Hajagos, JAMA Network Open	2021	239
An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activation Oded Livnah, Dana L. Johnson, E.A. Stura, Nature Structural Biology Molecular PharmacologyAntagonist Peptide–epo ReceptorSignal TransductionBiochemistryG Protein-coupled Receptor	1998	217
Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury Alaa S. Awad, Hanning You, Ting Gao, Kidney International InflammationGlomerulonephritisUrologyMedicineRenal Pathology	2015	190
Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGFβ1, IL-13 and CCL2 Lynne A. Murray, Rochelle L. Argentieri, Francis X. Farrell, The International Journal of Biochemistry & Cell Biology InflammationCytokineFibrosisInflammatory DiseaseImmune Regulation	2008	147
Erythropoietin Concentrations in Cerebrospinal Fluid of Nonhuman Primates and Fetal Sheep following High-Dose Recombinant Erythropoietin Sandra E. Juul, Ronald J. McPherson, Francis X. Farrell, Neonatology	2003	129
Increased potency of an erythropoietin peptide mimetic through covalent dimerization Nicholas C. Wrighton, Balasubramanian Palaniappan, Francis P. Barbone, Nature Biotechnology BiochemistryNatural SciencesPeptide LibraryPeptide SynthesisNon-peptide Ligand	1997	115
The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin Anargyros Xenocostas, Wing K. Cheung, Francis X. Farrell, European Journal of Clinical Pharmacology Intravenous AdministrationCerebrospinal FluidHematologyPharmacologyRecombinant Human Erythropoietin	2005	107
Identification of a 13 Amino Acid Peptide Mimetic of Erythropoietin and Description of Amino Acids Critical for the Mimetic Activity of EMP1 Dana L. Johnson, Francis X. Farrell, Francis P. Barbone, Biochemistry Mimetic ActivityProtein FunctionBiochemistryG Protein-coupled ReceptorNatural Sciences	1998	101
Serum Inflammatory and Immune Mediators Are Elevated in Early Stage Diabetic Nephropathy. Alan Perlman, James M. Chevalier, Patrick Wilkinson, PubMed	2015	89
Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor–positive breast carcinoma models Kenneth R. LaMontagne, Jeannene Butler, Deborah J. Marshall, Molecular Cancer Therapeutics	2006	81

Page 1